Home > Specialists > Medical Oncology > Dr. Lixin Qiu (邱立新)
Specialty & Clinical Focus:
Medical oncologist at Fudan University Shanghai Cancer Center in Shanghai, specializing in gastrointestinal cancers including gastric, colorectal and esophageal cancers, as well as hepatobiliary and pancreatic cancers, GIST, neuroendocrine tumors, immunotherapy and molecular targeted therapy.
Professional Title & Qualifications:
-
Associate Chief Physician
-
Associate Professor
-
Master Supervisor (M.D., Ph.D.)
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Medical Oncology
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Lixin Qiu (邱立新) - Medical Oncology Specialist
Personal Biography
Dr. Lixin Qiu is an Associate Chief Physician and Associate Professor in the Department of Medical Oncology at Fudan University Shanghai Cancer Center in Shanghai, with more than two decades of clinical experience focused on gastrointestinal malignancies. He earned his Ph.D. from Fudan University Shanghai Medical College in 2002. His clinical interests include gastric, colorectal and esophageal cancers, hepatobiliary and pancreatic cancers, GIST, neuroendocrine tumors, immunotherapy and molecular targeted therapy. He is recognized in the source material as the first specialist in China to apply PD-1 antibody immunotherapy for advanced gastric cancer. Dr. Qiu has also completed visiting scholar programs at MD Anderson Cancer Center, Johns Hopkins Hospital, Samsung Medical Center and the National Cancer Centre Singapore, and has participated in domestic and international clinical trials in gastrointestinal oncology.
Why Consider Dr. Lixin Qiu for Your Care?
Dr. Lixin Qiu may be particularly relevant for international patients seeking specialist input on gastrointestinal malignancies, hepatobiliary or pancreatic cancers, GIST, neuroendocrine tumors, or advanced solid tumors requiring systemic therapy. With more than two decades of experience in medical oncology at Fudan University Shanghai Cancer Center, his background combines gastrointestinal oncology practice with clinical-trial experience in immunotherapy and molecular targeted therapy. His visiting scholar experience at MD Anderson Cancer Center, Johns Hopkins Hospital, Samsung Medical Center and the National Cancer Centre Singapore adds an international dimension to his professional background. The source material also identifies him as the first specialist in China to apply PD-1 antibody immunotherapy for advanced gastric cancer. For a remote specialist review or pre-travel review, preparing pathology reports, imaging, prior treatment records and a focused question list can help Dr. Qiu review the case efficiently and provide a more case-specific specialist opinion before travel.
Pre-Travel Case Review & Specialist Liaison
Before committing to international travel, you can request MedBridgeNZ coordination for a remote specialist review with Dr. Qiu. We coordinate preparation of your existing medical records, medical-record translation where needed, and secure client-authorized transfer of the documentation to Dr. Qiu’s oncology team at Fudan University Shanghai Cancer Center. Under the arranged review pathway, Dr. Qiu will review the submitted records and provide his specialist opinion, recommendations and responses to your key questions.
This pre-travel review can help you better understand the options raised by the specialist before deciding whether to pursue an in-person pathway in China. If you decide to travel, MedBridgeNZ can then coordinate appointment communication, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative support in Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Lixin Qiu
Areas of Expertise
Gastrointestinal Cancers: Specializing in the diagnosis and treatment of Gastric Cancer, Colorectal Cancer, and Esophageal Cancer.
Hepatobiliary & Pancreatic Cancers: Expertise in Pancreatic Cancer, Biliary Tract Tumors, and Liver Cancer.
Rare Tumors: Treatment of Gastrointestinal Stromal Tumors (GIST) and Neuroendocrine Tumors.
Advanced Therapies: Highly experienced in Immunotherapy (PD-1/PD-L1 inhibitors) and Molecular Targeted Therapy for advanced solid tumors.
Palliative Care: Comprehensive management of advanced cancer symptoms.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
43,000 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2002 – Present: Department of Medical Oncology, Fudan University Shanghai Cancer Center (Shanghai, China).
Visiting Scholar: MD Anderson Cancer Center (USA).
Visiting Scholar: Johns Hopkins Hospital (USA).
Visiting Scholar: Samsung Medical Center (South Korea).
Visiting Scholar: National Cancer Centre Singapore.
Education & Training
Ph.D., Fudan University Shanghai Medical College (2002).
Awards & Honors
Academic & Professional Memberships
Member of the Chinese Society of Clinical Oncology (CSCO).
Member, Professional Committee of Integrative Medicine for Liver and Gallbladder Tumors, Shanghai Anti-Cancer Association.
Standing Committee Member & Secretary, Youth Council of Cancer Rehabilitation and Palliative Care, Shanghai Anti-Cancer Association.
Member, Professional Committee of Clinical Drug Research, Shanghai Anti-Cancer Association.
Reviewer for medical journals including the Chinese edition of the Journal of Clinical Oncology (JCO).
Research & Publications
Pioneering Treatment: Recognized as the first specialist in China to use PD-1 antibody therapy for advanced gastric cancer.
Publications: Published over 50 academic papers in SCI-indexed journals.
Grants: Principal Investigator for projects funded by the National Natural Science Foundation of China.
Clinical Trials: Active participant and leader in numerous domestic and international clinical trials focusing on gastrointestinal oncology.
Selected Peer-Reviewed Publications
Zhu XD, et al. XELOX doublet regimen versus EOX triplet regimen as first-line treatment for advanced gastric cancer: An open-labeled, multicenter, randomized, prospective phase III trial (EXELOX). Cancer Commun (Lond). 2022;42(4):314–326. PMID: 35212487
Zhao X, et al. Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial. Cancer Biol Med. 2023;20(9):682–8. PMID: 37653589
Zhang X, et al. FOLFIRI increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial. Ther Adv Med Oncol. 2022;14:17588359211068737. PMID: 35069808
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Qiu's clinical expertise suitable for my specific cancer diagnosis?
Dr. Qiu’s clinical focus includes gastrointestinal cancers such as gastric, colorectal and esophageal cancer, as well as hepatobiliary and pancreatic cancers, GIST, neuroendocrine tumors, immunotherapy and molecular targeted therapy for advanced solid tumors. If you are unsure whether your case fits his clinical scope, MedBridgeNZ can coordinate a remote specialist-review pathway using your existing medical records, pathology reports, imaging and prior treatment history. Under the arranged review, Dr. Qiu will review the submitted materials and provide his specialist opinion, recommendations and responses to your key questions.
How can an international patient request an appointment with Dr. Qiu?
International patients can ask MedBridgeNZ to coordinate appointment communication with Fudan University Shanghai Cancer Center. We help organize the required medical records, coordinate translation where needed, transfer client-authorized documentation to the relevant specialist team, and manage scheduling communication for a remote specialist review or an in-person hospital appointment. If you later decide to travel to Shanghai, MedBridgeNZ can also coordinate medical invitation or visa-document support, travel planning and non-clinical bilingual administrative support for your hospital visit. Appointment timing follows the hospital’s scheduling process.
What does a remote specialist review involve before traveling to China?
Before travel, MedBridgeNZ coordinates preparation and secure transfer of your existing medical records, diagnostic imaging, pathology reports, prior treatment information and key questions for Dr. Qiu’s review. Dr. Qiu will review the submitted materials and provide specialist feedback on the case, including relevant treatment recommendations and responses to your questions. MedBridgeNZ coordinates the records workflow, translation and communication around the review so you can better understand the specialist’s perspective before deciding whether to pursue an in-person pathway at Fudan University Shanghai Cancer Center.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-care pathways in China. We coordinate appointment requests, medical-record preparation, translation, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative support for hospital visits. For patients considering Dr. Lixin Qiu at Fudan University Shanghai Cancer Center, we can also coordinate the pre-travel records and communication needed for a structured specialist-review pathway. MedBridgeNZ does not provide medical advice, diagnosis or treatment; clinical opinions and treatment recommendations come from the relevant licensed specialist or hospital.